Rapsyn, an acetylcholine receptor (AChR)-interacting protein, is essential for synapse formation at the neuromuscular junction (NMJ). Like many synaptic proteins, rapsyn turns over rapidly at synapses. However, little is known about molecular mechanisms that govern rapsyn stability. Using a differential mass-spectrometry approach, we identified heatshock protein 90b (HSP90b) as a component in surface AChR clusters. The HSP90b-AChR interaction required rapsyn and was stimulated by agrin. Inhibition of HSP90b activity or expression, or disruption of its interaction with rapsyn attenuated agrin-induced formation of AChR clusters in vitro and impaired the development and maintenance of the NMJ in vivo. Finally, we showed that HSP90b was necessary for rapsyn stabilization and regulated its proteasome-dependent degradation. Together, these results indicate a role of HSP90b in NMJ development by regulating rapsyn turnover and subsequent AChR cluster formation and maintenance.
INTRODUCTION
Synapses are fundamental units for efficient communication between neurons and their target cells. Despite significant progress in understanding the structure of matured synapses, less is known about the mechanisms by which neurotransmitter receptors are targeted to and anchored at postsynaptic regions (Sanes and Lichtman, 2001; Waites et al., 2005) . Increasing evidence suggests that they are mobile, and exchanges occur continually between synaptic and extrasynaptic pools (Akaaboune et al., 1999) . This process is regulated by proteins that interact directly with the receptors or indirectly via adaptor proteins. Several such proteins have been identified, including transmembrane AMPAR regulatory proteins (TARPs) for AMPA receptors, PSD-95 for NMDA receptors, homer for mGlu receptors, and gephyrin for GABA receptors (Collingridge et al., 2004; Elias et al., 2006; Waites et al., 2005) . Due to easy accessibility and peripheral location, the neuromuscular junction (NMJ) has served as an informative model for synaptogenesis (Sanes and Lichtman, 2001 ). Synaptic concentration of AChRs is generated by complex interactions between motoneuron terminals and skeletal muscles, resulting in AChR aggregation and local synthesis (Fu et al., 2008; Li et al., 2008; Sanes and Lichtman, 2001; Schaeffer et al., 2001) . Neural agrin clusters AChRs via activating the transmembrane tyrosine kinase MuSK (DeChiara et al., 1996; Gautam et al., 1996; Glass et al., 1996; Herbst and Burden, 2000; McMahan et al., 1992; Zhou et al., 1999) , whereas ACh is thought to disassemble receptor clusters in nonsynaptic areas via activating muscle fibers (Brandon et al., 2003; Lin et al., 2005; Misgeld et al., 2002) . MuSK is also critically involved in the prepatterning of muscles because aneural AChR-rich sites are absent in MuSK knockout mice (Kim and Burden, 2008; Lin et al., 2001 ). The intracellular pathway downstream of MuSK remains unclear. It is thought to involve the adaptor protein Dok-7 (Okada et al., 2006) and several enzymes, including Src-family kinase (Ferns et al., 1996; Mittaud et al., 2001; Mohamed et al., 2001; Qu and Huganir, 1994; Wallace, 1991) , Abl (Finn et al., 2003) , geranylgeranyl transferase I (GGT) (Luo et al., 2003) , GTPases of the Rho family (Weston et al., 2000 (Weston et al., , 2003 , and Pak1, a serine/threonine kinase that is activated by Rho GTPases (Luo et al., 2002) .
Rapsyn is a key cytoplasmic protein in concentrating AChRs at the NMJ (Sanes and Lichtman, 2001) . Rapsyn À/À mice lack differentiated NMJs and fail to form AChR clusters (Gautam et al., 1995) . Rapsyn interacts with the AChR, which is increased by agrin and correlates with cytoskeletal linkage of the AChR (Moransard et al., 2003) . Recent evidence suggests that rapsyn regulates AChR clustering by inhibiting the activation of Cdk5 (Chen et al., 2007) and by associating with the b-catenin/a-catenin complex (Zhang et al., 2007) . Interestingly, rapsyn turns over rapidly, with a half-life of one to several hours in muscle cells (Bruneau and Akaaboune, 2007; Frail et al., 1989) . How the stability of rapsyn is regulated and contributes to AChR clustering and NMJ formation remains unclear.
To study the mechanisms of AChR clustering, we sought to identify proteins that became associated with aggregated surface AChRs in intact muscle cells using a differential proteomic approach. We identified HSP90b, a molecular chaperone implicated in stability and function of client proteins (Pearl and Prodromou, 2006) . Its association with surface AChRs was via direct interaction with rapsyn and was increased by agrin. We explored the consequences of inhibiting HSP90b activity or expression and of disrupting its interaction with rapsyn. Results of these experiments indicate a role of HSP90b in NMJ development by regulating rapsyn turnover and subsequent AChR cluster formation and maintenance.
RESULTS

Identification of HSP90b in the Complex of Surface AChR Clusters
To understand the mechanisms of AChR clustering, we attempted to identify proteins that are preferentially associated with aggregated versus diffused AChRs. Live, intact C2C12 muscle cells were incubated with biotin-conjugated a-bungarotoxin (aBTX) to label surface AChR following treatment with or without agrin. Receptor-associated proteins were purified by streptavidin-coupled agarose beads, resolved by SDS-PAGE, and identified by mass spectrometry. This led to the identification of several proteins, including HSP90b and rapsyn, a protein known to interact with AChR upon agrin stimulation (Figures 1A and 1B) (Moransard et al., 2003) . HSP90b is a chaperone ATPase of the HSP90 family implicated in protein maturation and targeting. Expression of HSP90b is not inducible with stress, unlike HSP90a, whose level increases in cells under stress. HSP90a was not detectable in surface AChR complexes regardless of agrin stimulation ( Figure 1C ), demonstrating the specificity of the interaction between HSP90b and surface-aggregated AChR. Moreover, the HSP90b association was time dependent, peaking ($8-fold above basal) around 12 hr after agrin stimulation ( Figures 1C and 1D ), a time when induced AChR clusters are detectable. Note that levels of HSP90b and surface AChR remained unchanged under these conditions ( Figure 1C ). In agreement, the amount of AChR was increased in HSP90b precipitates in reciprocal experiments ( Figure 1E ). HSP90b immunoreactivity showed a pattern similar to that of rhodamineconjugated aBTX (R-BTX) staining in developing and adult muscles ( Figures 1F and 1G ), but not in spontaneous clusters in cultured myotubes (Figure S1B available online), suggesting that HSP90b is enriched at the NMJ. These observations reveal that HSP90b associates with surface AChRs upon agrin stimulation. HSP70 also associated with surface AChRs. However, this association did not appear to be regulated by agrin ( Figure 1C ).
HSP90b Associates with AChR via Rapsyn
Next, we examined whether rapsyn associates with HSP90b in a manner dependent upon agrin stimulation. Immunoprecipitation with an anti-rapsyn antibody ( Figure S2 ) brought down HSP90b, and the coprecipitation was increased in agrin-stimulated cells (Figures 2A and 2B) . In reciprocal experiments, more rapsyn coprecipitated with HSP90b upon agrin stimulation ( Figure 2C) . Moreover, the rapsyn-HSP90b association was detectable in mouse muscle homogenates ( Figure 2D ), suggesting in vivo interaction of the two proteins. Intriguingly, rapsyn could also interact with HSP70 in an agrin-independent manner (Figures 2A and 2C) . In domain mapping experiments, GST-rapsyn was able to pull down wild-type and truncation mutant HSP90b1-620 ( Figure 2E ), suggesting that the C-terminal region could be dispensable for the interaction. Deletion of aa 440-620, however, prevented HSP90b from interacting with rapsyn, suggesting the necessity of this region ( Figures 2E and 2F) . Moreover, a GST fusion protein containing aa 440-620 was able to interact with [
35 S]-labeled rapsyn generated by in vitro translation ( Figure 2G ), suggesting that aa 440-620 is sufficient for interaction. This result also demonstrated that the interaction between HSP90b and rapsyn is direct. Rapsyn has three domains: TPR domains for self-association, a coiled-coil domain for interaction with AChR, and a Ring domain for interaction with b-dystroglycan (Bartoli et al., 2001) . The TPR domains appeared to be necessary and sufficient for interaction with HSP90b ( Figure S3 ). Direct interaction between HSP90b and rapsyn could suggest that HSP90b may associate indirectly with surface AChRs, i.e., via rapsyn. This hypothesis predicts that AChR is not associated with HSP90b in the absence of rapsyn. To test this, we used muscle cells derived from rapsyn mutant mice (clone 11-7) that are deficient in rapsyn and do not form AChR clusters in response to agrin (Apel et al., 1997; Fuhrer et al., 1999) . As shown in Figure 2H , rapsyn as well as HSP90b became associated with surface AChRs in agrin-stimulated control muscle cells (clone 12-10) derived from heterozygous littermates. In contrast, however, HSP90b was barely detectable in surface AChRs in rapsyn À/À myotubes ( Figure 2H ). Similarly, AChR was not detectable in precipitates of HSP90b in rapsyn À/À cells ( Figure S4 ). Note that levels of HSP90b and AChR were similar between control and rapsyn À/À myotubes. These results demonstrate the dependence of the HSP90b-AChR association on rapsyn and that agrin stimulates the interaction between rapsyn and HSP90b. In support of this, HSP90b and rapsyn were colocalized in agrin-stimulated C2C12 myotubes ( Figure 2I ) and the developing NMJ ( Figure S1A ).
Inhibition of HSP90b Attenuates AChR Cluster Formation In Vitro and In Vivo
To investigate the function of HSP90b in AChR clustering, muscle cells were treated with 17-(allylamino)-17-demethoxygeldanamycin (17-AAG), an inhibitor of HSP90 (Sharp and Workman, 2006) . It inhibits the ATPase activity by binding to the N-terminal region and thus alters the conformation of HSP90b and the chaperone complex (Stebbins et al., 1997) . 17-AAG (5 mM, 12 hr) had no apparent effect on myotube viability or morphology of C2C12 myotubes (data not shown). However, it inhibited agrin-induced formation of AChR clusters in a dose-dependent manner ( Figure 3A ) without altering the levels of surface AChR ( Figure 3B ), MuSK, or its activation by agrin or c-Abl, Rac, or Cdc42 ( Figures 3C and 3D) . A similar inhibitory effect was observed in myotubes pretreated with 17-AAG ( Figure S5 ). Intriguingly, 17-AAG (0.1 mM, 12 hr) dramatically reduced the amount of rapsyn associated with surface AChRs without significant changes of that in lysates, while at increased concentrations the amount of rapsyn in lysates was reduced (Figures 3B and 3E) . These results suggest a role for HSP90b in promoting rapsyn stability (see below). Concomitantly, the amount of HSP90b in the AChR complex, but not in lysates, was reduced ( Figure 3B ). These results suggest that inhibition of HSP90b attenuates its interaction with rapsyn and thus reduces the latter's stability, and subsequently, AChR cluster formation is compromised. Consistent with this model, the stability of AChR clusters in 17-AAG-treated muscle cells was reduced, with a half-life of about 4 hr in comparison with that of 7-12 hr in control cells ( Figure 3F ) (Camilleri et al., 2007; Kim and Nelson, 2000; Wallace, 1988; Zhu et al., 2006) . Time-lapse imaging indicated that 17-AAG treatment increased the rate of disappearance of AChR aggregates ( Figure S6 ). Thus, HSP90b may regulate both the formation and maintenance of AChR clusters.
We determined the role of HSP90b in NMJ formation in vivo by injecting 17-AAG intraperitoneally into embryos in utero at E14.5, a time when the NMJ starts to form (Lin et al., 2001; Zhu et al., 2006) . Diaphragms were whole-mount stained with antibodies against synaptophysin and neurofilament to label phrenic nerve branches and terminals and with R-BTX to label the AChR. As shown in Figure 4 , 17-AAG decreased the number and size of AChR clusters (Figures 4A and 4A 0 ) and reduced rapsyn immunoreactivity ( Figure 4B ), consistent with the notion that HSP90b regulates rapsyn stability and thus AChR cluster formation in vivo. Phrenic nerve branches and terminals were apparently similar in control and 17-AAG-treated muscles ( Figure 4A ). Due to the decrease in AChR clusters, numerous nerve terminals did not costain with R-BTX (arrow, Figure 4A 0 ), unlike control diaphragms where almost all terminals were associated with AChR clusters (arrowhead, Figure 4A 0 ). Note that 17-AAG injection reduced rapsyn levels in muscles (mostly in the synaptic region, Figures S7A and S7B) but had no apparent effect on the morphology of muscles, thickness of diaphragms, or size of muscle fibers ( Figure S8A ). No effect was observed on the morphology or number of motoneurons ( Figure S8B ) or distribution of ACh esterase (AChE), an enzyme enriched in the synaptic cleft of the NMJ ( Figure S8C ). These results suggest a role of HSP90b in NMJ formation. To determine whether it is also involved in NMJ maintenance, 17-AAG was injected intraperitoneally into P7, P14, and P30 mice, which reduced rapsyn in muscles ( Figure S9A ) but had no apparent effect on muscle fiber morphology or size ( Figure S9B ). Unlike NMJs in control mice that appeared like ''pretzels'' ( Figure 4C ), AChR clusters in 17-AAG-treated mice were disrupted. Quantitatively, the number of uninterrupted AChR cluster fragments was increased, whereas the area of each fragment, area of each NMJ, and intensity of AChR clusters were reduced in muscles of 17-AAGtreated mice ( Figure 4D ). The effect was age dependent, more severe in P7 mice. Consistent with biochemical and morphological deficits, 17-AAG-injected P7 and P14 mice showed a reduction in step length ( Figure S10 ). These data indicate a role of HSP90b in AChR cluster maintenance. Together with observations that HSP90b inhibition attenuates AChR clustering in cultured muscle cells, these observations provide evidence for a role of HSP90b in postsynaptic differentiation at the NMJ.
Repression of HSP90b Expression Inhibits AChR Clustering
To investigate specifically the role of HSP90b, we generated HSP90b miRNA constructs that inhibited HSP90b expression, among which 90b-1205 and 90b-1626 were most effective ( Figure 5A ). By contrast, HSP90b expression was not affected by a vector that encodes random sequences (control) or LacZmiRNA. HSP90b-miRNA constructs were introduced into C2C12 myotubes to avoid possible interference with muscle differentiation. Agrin-induced AChR clusters were analyzed in myotubes labeled by GFP, which was encoded by the miRNA vector. As shown in Figure 5C , AChR clustering was markedly attenuated in myotubes transfected with 90b-1205 and 90b-1626, in comparison with control. This effect was specific, as AChR clusters were not affected by 90a-2172 that suppressed HSP90a expression ( Figures 5B and 5C ). These results corroborate those from studies with the HSP90 inhibitor 17-AAG and demonstrate a role of HSP90b, not HSP90a, in agrin-induced AChR cluster formation in living myotubes.
To repress HSP90b expression in vivo, 90b-1205 DNA was delivered to tibialis anterior muscles of P14 mice by injection and subsequent electroporation, which enabled 67% muscle fibers to express GFP ( Figure S11 ). As shown in Figure 5D , 90b-1205 specifically repressed in vivo expression of HSP90b that was associated with decreased levels of rapsyn 2 weeks after electroporation. AChR clusters were examined in teased individual muscle fibers that express GFP. To ensure that AChRs under examination were formed in muscle fibers that expressed 90b-1205, we reconstructed 3D images of injected muscle fibers. Only clusters on GFP-expressing fibers, as indicated by lateral view of reconstructed 3D images ( Figure 5E ), were subjected to analysis and quantification. In comparison with control muscles, 90b-1205 disrupted AChR clusters in vivo. AChR clusters became fragmented, with reduced areas of individual fragments and of individual NMJs in 90b-1205-treated muscles ( Figures 5E and 5F ). The intensity of AChR clusters was also reduced ( Figure 5F ). Although 90a-2172 reduced levels of HSP90a in electroporated muscles, it had no detectable effect on rapsyn levels or in vivo AChR clustering ( Figures 5D-5F ). These data indicate that HSP90b, not HSP90a, is involved in AChR cluster maintenance.
Inhibition of AChR Clustering by an HSP90b Mutant
Next, we used a dominant-negative approach to investigate whether AChR clusters require the interaction of HSP90b and rapsyn. We reasoned that HSP90b1-620, a fragment that contains the domain for rapsyn interaction, may prevent endogenous rapsyn from interacting with HSP90b. As shown in Figure 6A , expression of Flag-HSP90b1-620 reduced levels of rapsyn in transfected muscle cells, presumably by disrupting the interaction between rapsyn and endogenous HSP90b. Remarkably, it inhibited agrin-induced AChR clusters in a manner that required the 440-620 domain that interacts with rapsyn. HSP90b constructs harboring this domain (1-620 and D233-439), but not those without this domain (1-232, 1-439, D440-620, and D233-620), were able to inhibit AChR clustering ( Figure 6B ). These results indicate that the HSP90b-rapsyn interaction may be involved in AChR cluster formation in muscle cells.
To disrupt the interaction in vivo, HSP90b1-620 was subcloned into pIRES2-EGFP to generate pIRES2-(1-620) that expresses EGFP and HSP90b1-620 as two individual proteins ( Figure 6C ). As shown in Figure 6E , HSP90b1-620 expression reduced rapsyn levels in injected muscles by 40%. AChR clusters were disrupted in HSP90b(1-620)-expressing muscle fibers, but not those expressing EGFP alone ( Figure 6D ). The number of AChR-positive fragments per NMJ was increased with reduced surface areas of each fragment and individual NMJ. These results, in good agreement with studies of AChR clusters in cultured myotubes ( Figure 6B ), indicate that disruption of the rapsyn-HPS90b interaction attenuates AChR clustering in vivo. Together with in vivo miRNA experiments, they provide strong evidence for an in vivo role of HSP90b in AChR clustering and NMJ formation.
HSP90b Stabilizes Rapsyn and Regulates Proteasome-Dependent Degradation
Rapsyn is a dynamic protein in the AChR complex with a half-life of one to several hours (Bruneau and Akaaboune, 2007; Frail et al., 1989) . The direct interaction between rapsyn and HSP90b may therefore regulate rapsyn stability. To test this hypothesis, we examined effects of 17-AAG on rapsyn stability in C2C12 myotubes in the presence of cycloheximide (CHX) to inhibit translation. As shown in Figure 7A , 17-AAG (5 mM) treatment promoted rapsyn degradation. The half-life of rapsyn decreased by 60% in treated muscle cells (6.1 ± 0.35 hr and 2.4 ± 0.15 hr in control and 17-AAG treated cells, respectively, p < 0.001, n = 7).
The reduction in rapsyn half-life could be attenuated by agrin ( Figure 7A ), which stimulates the HSP90b-rapsyn interaction (Figures 2A and 2C ). 17-AAG at the same concentrations was able to disrupt the HSP90b-rapsyn interaction in a time-dependent manner. The interaction was reduced within 20 min of and almost abolished 60 min after 17-AAG treatment ( Figure 7B) . Note that the effect of 17-AAG on rapsyn levels in lysates was also time dependent. 17-AAG (5 mM) had little effect on rapsyn levels within 60 min of treatment ( Figure 7B ), but reduced them significantly 12 hr after ( Figures 3B and 3E) . These results suggest that rapsyn stability was enhanced by interaction with HSP90b. This notion was supported by further studies with HSP90b-miRNA that reduced rapsyn in transfected cells ( Figure 7C ). Moreover, expression of HSP90b1-620, a deletion mutant that disrupts the HSP90b-rapsyn interaction, reduced rapsyn levels in a dose-dependent manner ( Figure 6A ).
Degradation of HSP90 client proteins is thought to be mediated by the 26S proteasome. As such, we investigated whether this system is involved in regulating rapsyn stability. Muscle cells were treated with MG-132, an inhibitor of the 26S proteasome, and rapsyn stability in control and 17-AAG-treated cells was characterized. As shown in Figure 7D , 17-AAG-induced degradation of rapsyn was attenuated by MG-132, but not by lysosomal protease inhibitors chloroquine or monensin. These results suggest that rapsyn undergoes degradation by 26S proteasomes. Consistent with this observation, MG-132 was able to attenuate the inhibitory effect of 17-AAG on AChR cluster formation ( Figure 7E ). Moreover, overexpression of rapsyn was able to attenuate the inhibitory effect of 17-AAG on AChR clusters ( Figure 7F ), suggesting the regulation of rapsyn levels could be a mechanism of action of HSP90b. Together, these results indicate that HSP90b was a synaptic chaperone that regulates the (C) Agrin-induced AChR clusters were reduced in myotubes expressing 90b-1205 or 90b-1626, but not 90a-2172. Young C2C12 myotubes were transfected with the control vector (scrambled) and indicated miRNA constructs and stimulated with agrin 24 hr later for 12 hr. AChR clusters were examined in myotubes expressing GFP that was encoded by the miRNA parental vector. Right panel shows quantitative analysis (mean ± SEM, n = 20 each group; **p < 0.01). (D) Decreased rapsyn levels in 90b-1205-expressing, but not 90a-2172-expressing, muscles. Indicated miRNA or control (scrambled) constructs were injected into tibialis anterior muscles of P14 mice. The injected muscles were subjected to electroporation. Fourteen days later, tibialis anterior muscles were homogenized and analyzed by immunoblotting with the indicated antibodies. Shown were representative blots and histograms of quantitative analysis (mean ± SEM, n = 5; **p < 0.01). (E) Fragmentation of AChR clusters in 90b-1205-expressing muscle fibers. miRNA or control constructs were injected as described in (D) into tibialis anterior muscles of P14 mice. AChR clusters were examined 2 weeks later in teased individual muscle fibers that express EGFP alone or EGFP and respective miRNA constructs. AChR clusters were visualized in single teased fibers, and Z serial images were collected and collapsed into a single image. Lateral view of the reconstructed 3D images was shown on the right. (F) Quantitative analysis of data in (E). Data shown were mean ± SEM, n = 30 AChR clusters of 6 mice of each group (**p < 0.01). Scale bar, 10 mm. stability of rapsyn and subsequently AChR clustering and NMJ formation.
DISCUSSION
Utilizing a proteomic approach, we identified HSP90b as a protein that becomes associated with surface AChR in agrin-stimulated muscle cells. We demonstrate that HSP90b does not interact with the AChR directly; instead, via direct interaction with rapsyn, HSP90b becomes associated with clustered AChR. Consistently, HSP90b is enriched at the NMJ and in AChR clusters in muscle cells. We show that HSP90b regulates AChR clustering. First, treatment of muscle cells with 17-AAG, an HSP90 inhibitor that disrupts the AChR-HSP90b complex, attenuated agrin-induced AChR clustering. 17-AAG also reduced the stability of AChR clusters. Second, suppression of HSP90b expres- sion inhibits agrin-induced AChR clustering in muscle cells. Third, disruption of the HSP90b-rapsyn interaction by a dominant-negative approach inhibits AChR clustering. Mouse embryos injected with 17-AAG form fewer AChR clusters, suggesting that HSP90b is involved in NMJ formation in vivo. Finally, we provide evidence that HSP90b regulates rapsyn stability. Rapsyn was reduced in muscle cells treated with 17-AAG, cells expressing HSP90b-miRNA that suppress HSP90b expression, and cells transfected with HSP90b1-620 that disrupts the interaction of endogenous HSP90b and rapsyn. These results support a working model where agrin stimulates the interaction between HSP90b and rapsyn and thus stabilizes rapsyn. When HSP90b is inhibited or its expression suppressed, rapsyn becomes unstable and degraded possibly via the 26S proteasome system. HSP90b was concentrated at the NMJ ( Figures 1F and 1G ) and present in agrin-induced AChR clusters ( Figure 3B ). However, little HSP90b was detectable in spontaneous AChR clusters ( Figure S1B ), although its association with surface AChR and rapsyn could be demonstrated in naive muscle cells in pulldown and coimmunoprecipitation assays ( Figures 1C and 2A) . These results could suggest that the amount of HSP90b (C) HSP90b depletion by miRNA facilitated rapsyn degradation. C2C12 myotubes were transfected with the control vector, LacZ-miRNA, or HSP90b miRNA constructs and lysed 36 hr later. Rapsyn in lysates was revealed by immunoblotting with indicated antibodies. Band density was quantified and shown in the histograms. Data were shown as mean ± SEM; n = at least 5 for each data point; ** or ##, p < 0.01. (D) Rapsyn reduction by 17-AAG was inhibited by MG-132, but not by lysosomal protease inhibitors. C2C12 myotubes were treated with vehicle (DMSO) or 17-AAG (5 mM) for 8 hr, with or without 10 mM MG-132, 10 mM chloroquine, or 10 mM monensin. In order to decrease toxicity, MG-132, chloroquine or monensin was added 4 hr before cell harvest. Lysates were subjected to immunoblotting with indicated antibodies. Quantitative analysis of results was shown in histograms (mean ± SEM, n = 4; **p < 0.01). (E) MG-132 attenuated 17-AAG-induced inhibition of AChR cluster formation. C2C12 myotubes were treated with agrin together with DMSO, 17-AAG (1 mM), MG-132 (5 mM), or 17-AAG plus MG-132. AChR clusters were assayed as in Figure 3 . Shown were mean ± SEM, n = 5; **p < 0.01. (F) Overexpression of rapsyn attenuated the inhibitory effect of 17-AAG on AChR clusters. C2C12 myotubes were transfected with the empty vector or rapsyn-HA. Thirty-six hours after transfection, cells were stimulated with agrin in the presence of DMSO or 5 mM 17-AAG. Lysates were probed with antibody against rapsyn, the HA tag, or b-actin (left panel). AChR clusters were examined in HA-positive myotubes in parallel experiments (right panel). Data were shown as mean ± SEM, n = 15 each group; **p < 0.01. associated with spontaneous AChR clusters was at low levels that could not be revealed by immunostaining. Nevertheless, these results suggest that HSP90b regulates agrin-regulated AChR clusters. This notion is supported by increased association of HSP90b with clustered AChR (Figure 1C, 1E, and 3B ).
HSP90b is a molecular chaperone that aids in the folding, assembly-disassembly, and activation of a wide range of substrate or client proteins (Pearl and Prodromou, 2006) . Many proteins are known to be enriched at the NMJ, including MuSK (DeChiara et al., 1996; Sanes and Lichtman, 2001) , and in particular, several have been identified to associate with the AChR of adult rabbit muscle cells or in cultured muscle cells, including APC, actin, and a-actinin (Mitsui et al., 2000; Wang et al., 2003) (data not shown). We show that HSP90b is recruited to the AChR complex upon agrin stimulation via direct interaction with rapsyn. Inhibition of HSP90b function by 17-AAG or by a dominant-negative mutant or suppression of HSP90b expression by miRNA reduces static levels of rapsyn and its half-life in myotubes. Moreover, rapsyn levels were reduced in muscles that expressed HSP90b-miRNA or the dominant-negative mutant or in muscles from mice that were injected with 17-AAG. These results suggest that HSP90b stabilizes rapsyn and subsequently AChR clustering. Intriguingly, pretreatment of myotubes with 17-AAG also inhibited agrin-induced formation of AChR clusters. This is probably because that the inhibition of HSP90b by 17-AAG is longlasting. A recent study indicates that 17-AAG accumulates in cells and its intracellular concentration remains high even 72 hr after treatment (Chiosis et al., 2003) . Interestingly, agrin stimulation did not have consistent effect on total levels of rapsyn in muscle cells, which could suggest that HSP90b alone is not sufficient for rapsyn folding or stabilization. In support of this notion was that HSP90b overexpression had no consistent effect on levels of rapsyn or its half-life ( Figure S12 ). These observations suggest the existence of additional mechanisms for rapsyn stabilization. In addition to HSP90b, rapsyn also associates with HSP70, another component of the HSP complex (Figures 2A  and 2C ). HSP70 is known to participate to regulate protein folding and degradation (Bukau and Horwich, 1998; Hartl and HayerHartl, 2002) . It is likely that HSP70 participates in rapsyn folding and stabilization.
It is worth pointing out that phenotypes of in vivo HSP90b inhibition were not identical to those observed in rapsyn mutant mice (Gautam et al., 1995) . Postsynaptically, junctional AChR clusters appeared fragmented, in addition to expected reduction in AChR intensity, in muscles injected with 17-AAG or expressing the dominant-negative mutant or HSP90b-miRNA ( Figures 4C,  6D , and 5E). Furthermore, in vitro studies showed that some AChR clusters disappeared whereas others reduced in intensity in myotubes ( Figure S6 time lapse) . This binary effect and fragmentation of AChR clusters could suggest a regulatory role of HSP90b in the stabilization of clusters or the NMJ, the underlying mechanisms of which, however, warrant further investigation. It is possible that HSP90b may regulate the function or stability of other proteins in addition to rapsyn. Candidates on this list include a-dystrobrevin and a-syntrophin, which have been shown to regulate the stabilization of AChR clusters (Adams et al., 2000; Banks et al., 2003; Grady et al., 2000; Pawlikowski and Maimone, 2008; Sadasivam et al., 2005) . In rapsyn mutant mice, motor axons grow excessively over the entire muscle with little presynaptic differentiation (Gautam et al., 1995) . However, nerve branches in 17-AAG-treated animals appeared to be similar to those in control mice ( Figure 4A and 4A 0 ). The lack of presynaptic phenotypes may be due to the time of 17-AAG injection, i.e., E14.5, being after the formation of primitive AChR clusters (Lin et al., 2001; Yang et al., 2001 ) and incomplete ablation of AChR clusters. It is also possible that HSP90b inhibition reduces axon mobility or suppresses expression of axon attractive molecules or trophic factors in muscles.
HSP90b inhibition did not appear to alter the levels of MuSK that is enriched in the postsynaptic membrane ( Figures 3C and  3E) . No consistent effect of HSP90b inhibition was observed on expression of signaling molecules that have been implicated in AChR clustering, including Abl, Rac, and Cdc42 ( Figure 3D ) or myosin heavy chain (MHC), MyoD, or myogenin ( Figure S7A ). These observations indicate the specificity of HSP90b-dependent protein stability, suggesting the necessity of direct interaction for HSP90b regulation. Rapsyn has been shown to confer AChR stability (Banks et al., 2003; Willmann and Fuhrer, 2002) . However, AChR is much more stable than rapsyn, with a halflife of $24 hr in muscle cells (Berg and Hall, 1975; Devreotes and Fambrough, 1975; Gervasio and Phillips, 2005; Wang et al., 1999) . The receptor becomes more stable when clustered or at the NMJ, with a half-life of $10 days (Levitt et al., 1980; Salpeter and Loring, 1985) . Therefore, we anticipate reduced levels of AChR after long-term inhibition of HSP90b.
HSP90 has three regions: N-terminal nucleotide binding pocket for ATP and geldanamycin, the middle region for substrate/client proteins, and the C-terminal region that interact with cochaperone proteins such as HSP70, HSP40, and p23 (Pearl and Prodromou, 2006) . The interaction with the cochaperones has been shown to regulate proper folding or function of substrate proteins. In line with this notion, we found that the C-terminal truncation mutant of HSP90b1-620 was unable to maintain rapsyn stability, although it was able to bind with rapsyn ( Figures 2E) . In fact, due to its ability to interact with rapsyn, expressed HSP90b1-620 attenuates the interaction of endogenous rapsyn and HSP90b and thus inhibits agrin-induced AChR cluster formation. These results demonstrate that the C terminus of HSP90b is involved in regulating the stability of rapsyn, suggesting the possible involvement of other chaperone proteins. Note that HSP90b overexpression did not appear to alter agrin-induced AChR clusters ( Figure 6B ) and had no consistent effect on levels of rapsyn or its half-life ( Figure S12 ), suggesting that the limiting factor may not be the levels of HSP90b, but the regulated interaction with rapsyn. Exactly how rapsyn is degraded after dissociation from HSP90b remains to be fully elucidated. The inhibition of 17-AAG-induced depletion of rapsyn by MG-132 suggests that degradation occurs via 26S proteasomal-dependent hydrolysis. This conclusion is further supported by our observations that the lysosomal protease inhibitors, chloroquine and monensin, had no effect on 17-AAG-induced loss of rapsyn.
In summary, this study reveals that the stability of rapsyn is critically dependent on HSP90b, highlighting a novel function of HSP90b in NMJ formation and maintenance. It also identifies a mechanism in agrin signaling for AChR clustering, i.e., by upregulating the interaction between HSP90b and rapsyn. Agrin is known to increase rapsyn interaction with AChR, which reaches maximal levels within 40 min of stimulation (Moransard et al., 2003) . We show that levels of HSP90b in the surface AChR complex begin to increase $1 hr after stimulation and peak around 12 hr ( Figure 1C ). These observations suggest that the initial targets of agrin/MuSK signaling include the interaction of the AChR and rapsyn, which is followed by the rapsyn-HSP90b association. Recruited HSP90b maintains the stability of rapsyn associated with surface AChRs, contributing to cluster formation and maintenance (Figure 8 ). Considering that several members of the HSP90 machinery are present at the PSD or aggresomes in neurites (Moon et al., 2001; Romorini et al., 2004; Suzuki et al., 1999; Walikonis et al., 2000) , these results may provide insight into CNS synapse formation. In support of the notion, pharmacological inhibitors of HSP90 have been shown to rapidly reduce AMPA receptor currents in hippocampal slices, probably by interfering with constitutive trafficking of AMPA receptors (Gerges et al., 2004) .
EXPERIMENTAL PROCEDURES
Reagents, Constructs, and Antibodies Biotin-conjugated aBTX, R-BTX, streptavidin-coupled agarose beads, goat anti-mouse IgG conjugated with Alexa Fluor 488, donkey anti-rabbit IgG conjugated with Alexa Fluor 488, and goat anti-mouse IgG conjugated Alexa Fluor 594 were from Molecular Probes. MG-132 (Z-Leu-Leu-Leu-CHO, I-130) was from BostonBiochem. Interferon-g was from BioSource. 17-AAG, CHX, Lubrol-PX, and other chemicals were from Sigma (St. Louis, MO). Mouse HSP90b was subcloned between EcoR V and Xho I in pcDNA-Flag, pcDNA3.1-Myc/His, or between Xho I and Sal I sites in pIRES2-EGFP (Addgene). Mouse rapsyn was subcloned between Hind III and Xba I sites in pKH3 or between EcoR I and BamH I sites in pEGFP-N1 (BD Biosciences Clontech) inframe upstream of the GFP epitope. Rapsyn was subcloned between BamH I and EcoR I sites in pEF6/myc-his (Invitrogen) or in pGEX-2T. Respective deletion mutants were generated by using the Quick Change Site-Directed Mutagenesis Kit (Stratagene). The authenticity of all constructs was verified by DNA sequencing. The immunogen to generate the anti-HSP90b antibody was from Dr. David Toft (Mayo Clinic). GST-HSP90 mutant plasmids were a gift from Dr. Takenawa (Park et al., 2005) . HSP90a-and HSP90b-miRNA constructs were generated using the BLOCK-iT Pol II miR RNAi Expression Vector Kit (Invitrogene, K4936-00). Oligonucleotide sequences for miRNA constructs were as follows Agrin stimulates the interaction between AChR and rapsyn to initiate clustering process. Subsequently, HSP90b becomes associated with rapsyn. The latter interaction helps to stabilize rapsyn, contributing to AChR cluster formation and maintenance.
TTC TTC AGT TAC AGC AGC-3 0 . Antibodies were purchased from ZYMED (HSP90b, 37-9400), Santa Cruz (HSP90a, sc-8262; HSP70, sc-24; c-Abl, sc-131; Cdc42; sc-87; MyoD, sc304; MHC, sc32732), Sigma (FlagM2, F3165), Chemicon (neurofilament, AB1983), Dako (synaptophysin, A0010), Torrey Pines Biolabs (GFP, TP401), Upstate Biotechnology (4G10, 05-321; Rac, 05-389), Novus (b-actin, NB600-501), and Abcam (myogenin, ab1835). Rabbit anti-rapsyn (2741) and anti-MuSK antibodies were described previously (Luo et al., 2002) . Anti-AChR a-subunit (mAb35) and anti-AChRb-subunit (mAb124) antibodies were gifts from Dr. Rotundo and Dr. Lindstrom, respectively. Neural agrin was prepared as described previously and used at 10 ng/ml ($0.1 nM) unless otherwise indicated (Luo et al., 2002) .
Cell Culture and Transfection
Mouse muscle C2C12 myoblasts were propagated and induced to form myotubes as described previously (Luo et al., 2002) . Rapsyn À/À (clone 11-7) and control (clone 12-10) myoblasts were maintained and differentiated as described previously (Zhu et al., 2006) . C2C12 myoblasts were transfected with lipofectamine 2000 (Invitrogen, 11668-019) with a modified protocol. C2C12 myoblasts, at 70%-80% confluence, were rinsed once with serumfree medium before transfection because serum appeared to reduce transfection efficiency. After complete aspiration of the medium, myoblasts were incubated with a mixture of DNA, lipofectamine, and serum-free medium for 8 hr when the medium was changed to the growth medium. The DNA:lipofectamine ratio in the mixture was 1 mg:2 ml. The optimal volume of the mixture for 24-well dishes was 200 ml per well that contained 2 mg plasmid DNA. Using the modified protocol, we were able to achieve high transfection efficiency.
Isolation of Surface AChR and Associated Proteins
Myotubes were stimulated without or with agrin at 37 C for the indicated times and incubated live with 300 nM biotin-aBTX for 2 hr at 4 C. After washing, cells were lysed in the extraction buffer containing 0.5% Lubrol-PX, 50 mM KCl, 2 mM CaCl 2 , 4 mM MgCl 2 , 20% glycerol, 50 mM Tris-HCl, and inhibitors of proteases and phosphatases, pH 7.4. Lysates were incubated with streptavidin-coupled agarose beads for 6 hr at 4 C and washed extensively with the extraction buffer, except that the concentration of Lubrol-PX was 0.1%. Beadassociated proteins were resolved by SDS-PAGE. Bands were excised from gels, cut into 1 mm pieces, washed in 20 mM AMBIC, dried, and digested overnight in trypsin. Peptides were extracted using 5% FA in 50% CAN and were dried. Using a 1:1 dilution of CHCA matrix in 5%FA/50% ACN, samples were spotted to an ABI 4700 Proteomics Analyzer (Applied Biosystems) MALDI-ToF target plate. Four thousand shots were fired to acquire the initial MS spectrum, and the top 20 most intense peaks were selected for MS/MS analysis. Obtained sequences were used for database search with FASTA and BLAST program.
Immunoprecipitation, Immunoblotting, and In Vitro Protein Interactions Cell lysates were cleaned by centrifugation at 12,000 rpm for 10 min and subjected to immunoprecipitation with indicated antibodies and protein-A or protein-G beads (Roche) at 4 C overnight. Bound proteins were resolved by SDS-PAGE and analyzed by immunoblotting as described previously (Luo et al., 2002; Zhu et al., 2006) . In some experiments, membranes were stripped and reblotted with different antibodies as described (Luo et al., 2002; Zhu et al., 2006) . Quantification of immunoblots was done by scanning films containing nonsaturated signals with an Epson 1680 scanner and analyzed with NIH Image. GST-rapsyn proteins were produced in BL21, purified, and immobilized on glutathione Sepharose 4B beads (Amersham Pharmacia). They were incubated with cell lysates in pull-down experiments. To assay the direct interaction, GST-HSP90b proteins were produced in BL21, purified, and immobilized on beads. [
35 S]-labeled rapsyn was generated by in vitro translation in the presence of [ 35 S]methionine using TnT T7/SP6 Coupled Reticulocyte Lysate System (Promega) (Luo et al., 2002) and was incubated with immobilized GST-HSP90b in the binding buffer (25 mM HEPES, 1 mM DTT, 0.5% Triton X-100, and 150 mM NaCl and protease inhibitors, pH7.5) for 2 hr at 4 C on a rotator. After washing with PBS/0.1% Tween 20, bound [ 35 S]-labeled proteins were resolved on SDS-PAGE and subjected to autoradiogram.
AChR Cluster Assays
AChR clusters in C2C12 myotubes were measured as described previously (Luo et al., 2002; Zhu et al., 2006) . In some experiments, young myotubes (2 days after changing to the differentiation medium) were transfected with indicated constructs using the lipofectamine 2000 kit according to the manufacturer's instruction. 24-36 hr later, transfected myotubes were subjected to AChR cluster assays. For a particular treatment, at least 20 pictures were taken from several chamber slides. AChR clusters whose diameters or longer axis was equal to or greater than 4 mm were scored with Metamorph software.
17-AAG Injection
C57BL/6J mice were injected intraperitoneally at P7, P14, and P30 with 50 ml of 17-AAG (2.5 mg/kg) three times a week for 2 weeks. Control mice received equal volumes of DMSO. AChR clusters were visualized in single teased fibers of tibialis anterior muscles, and Z serial images were collected and collapsed into a single image. Mouse embryos in uterus (E14.5) were injected intraperitoneally with 17-AAG (10 ml, 0.5 mM in 10% DMSO), returned to the pregnant mice, and injected again at E15.5. Control embryos were injected with equal volumes of the vehicle DMSO (10%). Two days after second injection, embryos (E17.5) were dissected and processed for AChR staining as described previously (Dong et al., 2006; Li et al., 2008; Zhu et al., 2006) .
Intramuscular DNA Injection and Electroporation
In vivo electroporation was performed as previously described (Aihara and Miyazaki, 1998) with modification. Briefly, 14-day-old C57BL/6J mice were anesthetized with isoflurane. Respective miRNA were injected into the tibialis anterior muscles (5 mg DNA in 10 ml TE buffer). Contralateral muscles were injected with control plasmids that encode scrambled sequence. A pair of electrode needles with a 5 mm gap was inserted into the muscle to encompass the DNA injection sites, and electric pulses were delivered using an electric pulse generator (ECM830; BTX). Five pulses followed by five additional pulses of the opposite polarity were administered to each injection site. The parameters of the pulses were 50 V at 60 Hz with each pulse lasting for 50 ms. Fourteen days after electroporation, mice were sacrificed, and the tibialis anterior muscles were fixed in cold 4% PFA-PBS for 24 hr and stained with R-BTX. Individual muscle fibers were isolated and examined for AChR clusters under a Zeiss confocal laser-scanning microscope. Z serial images were collected and collapsed into a single image. AChR clusters on EGFP-positive fibers were analyzed with LSM 5 Image Examiner (Zeiss).
Statistical Analysis
Data of multiple groups were analyzed by ANOVA, followed by a student-Newman-Keuls test. Two-tailed Student's t test was used to compare data between two groups. Differences were considered significant at p < 0.05. Values and error bars in figures denote mean ± SEM.
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